[English] 日本語

- EMDB-48118: Map of Neuraminidase active site specific polycloncal antibody fr... -
+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Map of Neuraminidase active site specific polycloncal antibody from sera of 10 mice vaccinated with Indiana 2011 Group 2 Neuraminidase | |||||||||
![]() | ||||||||||
![]() |
| |||||||||
![]() | Neuraminidase / Antibody / Influenza / Mouse / Polyclonal / VIRAL PROTEIN | |||||||||
Biological species | ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.3 Å | |||||||||
![]() | Ferguson JA / Han J / Rodriguez AJ / Torres JL / Ward AB | |||||||||
Funding support | ![]()
| |||||||||
![]() | ![]() Title: Functional and epitope specific monoclonal antibody discovery directly from immune sera using cryo-EM. Authors: James A Ferguson / Sai Sundar Rajan Raghavan / Garazi Peña Alzua / Disha Bhavsar / Jiachen Huang / Alesandra J Rodriguez / Jonathan L Torres / Maria Bottermann / Julianna Han / Florian ...Authors: James A Ferguson / Sai Sundar Rajan Raghavan / Garazi Peña Alzua / Disha Bhavsar / Jiachen Huang / Alesandra J Rodriguez / Jonathan L Torres / Maria Bottermann / Julianna Han / Florian Krammer / Facundo D Batista / Andrew B Ward / ![]() ![]() Abstract: Antibodies are crucial therapeutics, comprising a substantial portion of approved drugs due to their safety and clinical efficacy. Traditional antibody discovery methods are labor-intensive, limiting ...Antibodies are crucial therapeutics, comprising a substantial portion of approved drugs due to their safety and clinical efficacy. Traditional antibody discovery methods are labor-intensive, limiting scalability and high-throughput analysis. Here, we improved upon our streamlined approach combining structural analysis and bioinformatics to infer heavy and light chain sequences from cryo-EM (cryo-electron microscopy) maps of serum-derived polyclonal antibodies (pAbs) bound to antigens. Using ModelAngelo, an automated structure-building tool, we accelerated pAb sequence determination and identified sequence matches in B cell repertoires via ModelAngelo-derived hidden Markov models (HMMs) associated with pAb structures. Benchmarking against results from a nonhuman primate HIV vaccine trial, our pipeline reduced analysis time from weeks to under a day with higher precision. Validation with murine immune sera from influenza vaccination revealed multiple protective antibodies. This workflow enhances antibody discovery, enabling faster, more accurate mapping of polyclonal responses with broad applications in vaccine development and therapeutic antibody discovery. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 483.4 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 17.2 KB 17.2 KB | Display Display | ![]() |
Images | ![]() | 73.8 KB | ||
Filedesc metadata | ![]() | 5.4 KB | ||
Others | ![]() ![]() | 475.5 MB 475.5 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Validation report
Summary document | ![]() | 1.2 MB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 1.2 MB | Display | |
Data in XML | ![]() | 18.9 KB | Display | |
Data in CIF | ![]() | 22.5 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
-
Links
EMDB pages | ![]() ![]() |
---|
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.725 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Half map: #1
File | emd_48118_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #2
File | emd_48118_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : A/Indiana/10/2011 Neuraminidase in complex with polyclonal antobodies
Entire | Name: A/Indiana/10/2011 Neuraminidase in complex with polyclonal antobodies |
---|---|
Components |
|
-Supramolecule #1: A/Indiana/10/2011 Neuraminidase in complex with polyclonal antobodies
Supramolecule | Name: A/Indiana/10/2011 Neuraminidase in complex with polyclonal antobodies type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
---|
-Macromolecule #1: A/Indiana/10/2011 Group 2 Neruaminidase Tetramer
Macromolecule | Name: A/Indiana/10/2011 Group 2 Neruaminidase Tetramer / type: protein_or_peptide / ID: 1 / Enantiomer: LEVO / EC number: exo-alpha-sialidase |
---|---|
Source (natural) | Organism: ![]() |
Recombinant expression | Organism: ![]() |
Sequence | String: MYSMQLASCV TLTLVLLVNS QHHHHHHGSS SSDYSDLQRV KQELLEEVKK ELQKVKEEII EAFVQELRKR GSLVPRGSGG EYRNWSKPQC NITGFAPFSK DNSIRLSAGG DIWVTREPYV SCDPDKCYQF ALGQGTTLNN GHSNNTVHDR TPYRTLLMNE LGVPFHLGTR ...String: MYSMQLASCV TLTLVLLVNS QHHHHHHGSS SSDYSDLQRV KQELLEEVKK ELQKVKEEII EAFVQELRKR GSLVPRGSGG EYRNWSKPQC NITGFAPFSK DNSIRLSAGG DIWVTREPYV SCDPDKCYQF ALGQGTTLNN GHSNNTVHDR TPYRTLLMNE LGVPFHLGTR QVCMAWSSSS CHDGKAWLHV CITGNDNNAT ASFIYNGRLV DSIGSWSKNI LRTQESECVC INGTCTVVMT DGSASGKADT KILFVEEGKI VHISTLSGSA QHVEECSCYP RFPGVRCVCR DNWKGSNRPI VDINVKNYSI VSSYVCSGLV GDTPRKSDSV SSSYCLDPNN EKGGHGVKGW AFDDGNDVWM GRTINETLRL GYETFKVIEG WSKANSKLQT NRQVIVEKGD RSGYSGIFSV EGKSCINRCF YVELIRGRKE ETKVWWTSNS IVVFCGTSGT YGTGSWPDGA DINLMPI |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Concentration | 0.5 mg/mL |
---|---|
Buffer | pH: 7.4 / Details: Tris-Buffered Saline |
Grid | Model: UltrAuFoil R1.2/1.3 / Material: GOLD / Mesh: 300 / Support film - Material: GOLD / Support film - topology: HOLEY / Pretreatment - Type: PLASMA CLEANING / Pretreatment - Time: 25 sec. |
Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277 K / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
Microscope | FEI TALOS ARCTICA |
---|---|
Image recording | Film or detector model: FEI FALCON IV (4k x 4k) / Number grids imaged: 3 / Number real images: 15368 / Average electron dose: 43.4 e/Å2 |
Electron beam | Acceleration voltage: 200 kV / Electron source: ![]() |
Electron optics | C2 aperture diameter: 100.0 µm / Calibrated defocus max: 1.8 µm / Calibrated defocus min: 0.8 µm / Calibrated magnification: 190000 / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 1.8 µm / Nominal defocus min: 0.8 µm / Nominal magnification: 190000 |
Sample stage | Specimen holder model: OTHER / Cooling holder cryogen: NITROGEN |
Experimental equipment | ![]() Model: Talos Arctica / Image courtesy: FEI Company |